WPSS.bio

Investing in most revolutionary diagnostics and interventions for mental health and wellbeing

[Jay @pu3he]

卧槽，这踏马太毒了

DeepMind 掌门人、诺奖得主 Demis Hassabis 刚刚把延续了上百年的现代学校教育底裤彻底扒光了：

全球几十万名数学老师每天关在办公室里，为同一门中学数学课重复手搓着一模一样的 PPT，这简直是人类智力资源最荒诞的工业级空转。

很多人至今还把名校名师的课堂讲授当成稀缺资源，拼了命去抢学区房和重点班，

但 Hassabis 直接用最冷酷的第一性原理砸碎了这个幻觉，

标准化的知识灌输从来不配占用昂贵的线下课堂，死记硬背和刷题完全应该被踢出教室，交给能按每个孩子毫秒级反应速度实时调频的私人 AI，加上全世界最顶尖的那几个大师录好底层大课，就足以把全球基础教育的讲授环节一次性彻底平替。

过去两百年里，学校本质上是一座把千差万别的碳基大脑强行塞进同一条流水线、按同一个节拍器拧螺丝的工业时代兵营，

老师沦为了人肉复读机，学生被困在枯燥的题海里比拼谁更像一台劣质硬盘，
而一旦 AI 和顶级大师把标准化的知识传递彻底接管，线下教室唯一剩下的合法存在价值，就只剩下了机器永远无法通过权重计算出来的五个维度：

人际博弈、复杂项目实战、创业野心、创造力，以及最致命的判断力。

这里有一个极度冷酷的反直觉真相：
当个性化 AI 把考高分的边际成本砸穿地板，按标准答案培养出来的做题家，在出校门的那一刻就已经直接沦为了算力废料。

未来的阶层分化，从来不再取决于谁的脑子里背下了更多现成的公式，
而是取决于当 AI 把一万种完美方案同时拍在桌上时，谁拥有拍板做决定的判断力，谁能攒起一个活人团队去把事情干成，

所以别再逼着孩子在死记硬背的泥潭里跟硅基芯片比拼记忆容量了，当流水线式的教书匠和做题家同时迎来历史性失业，谁能先把教室变成训练人性直觉与创业野心的实战沙盘，谁才能在算力时代拿到唯一不被平替的入场券

[WPSS.bio @wpss_bio]

@PatrickJBlum Please sign me up for this guide

[Aakash Gupta @aakashgupta]

2. AI to Detect Parkinson's

Researchers at the University of New South Wales developed an AI based approach to detect Parkinson's.

Such a method is sorely needed.

Source: The House of Wellness

[Microdose Psychedelic Insights @MicrodoseHQ]

Based on a preliminary prospectus just filed by ATAI, the major takeaways are hugely increased R&D spending and the expansion of their #patent portfolio. Let's take a closer look at the prospectus and what this could mean for @atai_life.
https://t.co/fCWZTatI9r

[Matt Baggott @mattbagg]

https://t.co/ej8uSf26So

[Florian Brand @flobrand]

Today we announce the collaboration of our platform company Perception with Otsuka Pharmaceuticals. The teams will develop and commercialize PCN-101 (R-ketamine) in Japan, with the goal of providing new options to patients suffering from TRD.

Read more: https://t.co/1MsDqvlBha

[Rick Doblin, Ph.D., of MAPS @RickDoblin]

@C_Angermayer @tferriss @michaelpollan @RCarhartHarris As @C_Angermayer notes, easier access to capital is a key advantage of for-profit psychedelic drug development over non-profit drug development reliant on philanthropy.

However, Christian is not correct that patents are essential to obtain exclusive rights to market a medicine.

[StanceGrounded @_SJPeace_]

A 7 year old girl is selling lemonade for brain surgery. Yet in the same society we have BILLIONAIRES.

Billionaires should not exist in a society where a 7 yr old child has to sell lemonade for surgery!

This not some a cute story. THIS IS OUTRAGEOUS!

[Roy Perlis @royperlis]

Just getting a study like this a) funded, b) through an IRB, and c) completed is an achievement. Notable that 870 people were screened to randomize 27. Wish they'd used a real control group, though - bdz+ptx, eg?

[WPSS.bio @wpss_bio]

Join us in celebrating the team at Compass Pathways behind their successful psychedelic IPO (NASDAQ: CMPS) ... a true game changer for global mental health.

https://t.co/udMdttk3ib

[Harvard Medical School @harvardmed]

More than 90% of people who responded to a nationwide survey reported feeling increased worry, frustration, boredom or anxiety during the ongoing coronavirus pandemic https://t.co/4vGhs6VGGj

[Robin Carhart-Harris @RCarhartHarris]

I'm pleased to share my first ever personally written piece for a newspaper: https://t.co/BkEbRW7UqP @guardian #mentalhealth #psychedelics @Imperial_PRG

[Elon Musk @elonmusk]

Selling weed literally went from major felony to essential business (open during pandemic) in much of America & yet many are still in prison. Doesn’t make sense, isn’t right.

[AtaiBeckley Inc @ataibeckley]

Always great to chat with @JavierHasse... hear from Jason Camm and ATAI founder @C_Angermayer on the future #psychedelics and #mentalhealth innovation (via @Forbes) https://t.co/NLIArArJTh

[Bruce Booth @LifeSciVC]

Biotech IPOs that price near overall $XBI $IBB market peaks (2015, 2018) tend in aggregate to underperform (= lower median post-mkt stock performance).

ICYMI: Here's a longer term view of IPO value creation, "Dispersion of Performance In Biotech IPOs" https://t.co/ScOuFAD0hl

[Christian Angermayer @C_Angermayer]

The #airlines and cruise industries should sponsor a $1 billion prize for any entrepreneur who invents a $5 #COVID19 test that can deliver results within an hour (or less) for use before boarding. And boom! They’re back in business @Delta @AmericanAir @lufthansa @RoyalCaribbean

[Boris D Heifets @TheBorisLab]

R-ketamine in humans, open label. Big effect, "dissociation was nearly absent". More evidence separating the subjective experience of ketamine from its persistent antidepressant effect.

https://t.co/oqlk6J0hQ2

[Shayla Love @shayla__love]

I wrote about an intriguing brain mystery: As far as we know, no person born blind has ever been diagnosed with schizophrenia. Why?
https://t.co/KOsgLZ6z3t

[Michael Pollan @michaelpollan]

Are Investors Ready To Change Their Minds About Psychedelic Drugs? https://t.co/NROqDXD5jo

[WPSS.bio @wpss_bio]

Great to see mental health, opioid crisis and psychedelics gaining the attention they deserve.
#timetoinvest
#WEF
#Davos2020

https://t.co/q26xxAFpZ7